The impact of rate and rhythm control strategies on quality of life for patients with atrial fibrillation: a protocol for a systematic review

Author:

Uruthirakumar Powsiga,Surenthirakumaran Rajendra,Gooden Tiffany E.,Lip Gregory Y. H.,Thomas G. Neil,Moore David J.,Nirantharakumar Krishnarajah,Kumarendran Balachandran,Subaschandran Kumaran,Kaneshamoorthy Shribavan,Sheron Vethanayagam Antony,Guruparan Mahesan,Arasalingam Ajini,Beane Abi,Bensenor Isabela M.,Brocklehurst Peter,Cheng Kar Keung,Santos Itamar S.,El-Bouri Wahbi,Feng Mei,Goulart Alessandra C.,Greenfield Sheila,Guo Yutao,Gusso Gustavo,Haniffa Rashan,Humphreys Lindsey,Jolly Kate,Jowett Sue,Lancashire Emma,Lane Deirdre A.,Li Xuewen,Li Yan-guang,Lobban Trudie,Lotufo Paulo A.,Manseki-Holland Semira,Olmos Rodrigo D.,Paschoal Elisabete,Pirasanth Paskaran,Powsiga Uruthirakumar,Romagnolli Carla,Shantsila Alena,Shribavan Kanesamoorthy,Szmigin Isabelle,Subaschandren Kumaran,Tai Meihui,Varella Ana C.,Wang Hao,Wang Jingya,Zhang Hui,Zhong Jiaoyue,

Abstract

Abstract Background Atrial fibrillation (AF) is the most common heart arrhythmia globally and it adversely affects the quality of life (QoL). Available rate and rhythm control strategies equally reduce mortality but may impact QoL differently. A number of systematic reviews have focused on the impact of specific strategies on QoL, though a 2006 review synthesized the evidence on the effect of all strategies on QoL, allowing for a clinically important comparison between the types of strategies. Many trials have been published since the review undertook the search in 2005; therefore, an update is needed. This systematic review aims to provide an update to the 2006 review on the impact of all rate and rhythm control strategies on QoL in people with AF. Methods The following four databases and three clinical trial registries will be searched for primary studies: CENTRAL, MEDLINE, Embase, CINAHL, WHO International Clinical Trials Registry Platform, ClinicalTrials.gov, and ClinicalTrialsRegister.eu. No language restriction will be applied. The search will be limited to 2004 or later publication year to allow overlap with the search conducted by the 2006 review authors. Any randomized control trial that reports the QoL of adult (≥ 18 years) AF patients following an eligible rate or rhythm control intervention will be eligible for inclusion. Eligible interventions (and comparators) include pacing, atrioventricular node junction and bundle of HIS ablation, pharmacological therapy, radio frequency catheter ablation, cryoablation, pulmonary vein isolation, maze operation, pace maker implantation, and defibrillator implantation. Two reviewers will independently screen for eligible studies, extract the data using a piloted tool, and assess bias by QoL outcome using the RoB 2 tool. The suitability of conducting a meta-analysis will be assessed by the clinical and methodology similarities of included studies. If it is feasible, standardized mean differences will be pooled using a random-effects model and assessed appropriately. Discussion The findings from this review will allow for meaningful comparisons between various rate and rhythm control strategies regarding their impact on QoL. This review will be useful for a wide range of stakeholders and will be crucial for optimizing the overall wellbeing of AF patients. Systematic review registration PROSPERO CRD42021290542

Funder

National Institute for Health Research

Publisher

Springer Science and Business Media LLC

Subject

Medicine (miscellaneous)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3